# Spectrometry (MRM) Versus I 125 Radioimmunoassay (RIA) for Quantification of Orexin-A of Patients With Hypersomnolence

> **NCT05615584** · NA · RECRUITING · sponsor: **University Hospital, Montpellier** · enrollment: 117 (estimated)

## Conditions studied

- Narcolepsy
- Idiopathic Hypersomnia
- Cataplexy

## Interventions

- **DIAGNOSTIC_TEST:** Quantitative mass spectrometry assay

## Key facts

- **NCT ID:** NCT05615584
- **Lead sponsor:** University Hospital, Montpellier
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-02-15
- **Primary completion:** 2025-07-30
- **Final completion:** 2025-10-30
- **Target enrollment:** 117 (ESTIMATED)
- **Last updated:** 2024-05-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05615584

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05615584, "Spectrometry (MRM) Versus I 125 Radioimmunoassay (RIA) for Quantification of Orexin-A of Patients With Hypersomnolence". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05615584. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*